Profile
| Metric | Value |
|---|---|
| Full Name | ALX Oncology Holdings Inc. |
| Ticker | NASDAQ: ALXO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | alxoncology.com |
| Employees | 65 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.47 | |
| Price, 1D Change | 0.00% | |
| $80M | ||
| - | ||
| - | ||
| 1.01 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.58 | ||
| EPS, 1Y Change | +30.91% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.58 | ||
| EPS Estimate | -$1.56 | |
| EPS Est. Change | +39.64% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $1.47 | |
| Price Target | - | $3.00 |
| Price Tgt. Change | - | +104.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.44 | -$3.74 | -8.74% | |
| -$1.72 | -$2.58 | -49.95% | |
| -$1.56 | N/A | +39.64% | |
| -$0.75 | N/A | +70.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.47 | |
| $1.00 | ||
| SMA 200 vs Price | -32.18% | |
| $1.36 | ||
| SMA 50 vs Price | -7.46% | |
| 1.01 | ||
| $0.13 | ||
| 57.12 | ||
| 129.13% | ||
| 123.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.58 | ||
| -$872.00K | ||
| - | ||
| -$142.47M | ||
| - | ||
| -$134.85M | ||
| - | ||
| -$132.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.15 | ||
| 7.26 | ||
| 7.26 | ||
| - | ||
| - | ||
| -6.52 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.78 | ||
| -0.32 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $113.62M | ||
| $17.57M | ||
| $147.78M | ||
| $134.35M | ||
| $34.16M | ||
| $18.50M | ||
| $16.98M | ||
| $2.35M | ||
| $4.50M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $142.47M | ||
| $142.47M | ||
| $872.00K | ||
| $26.09M | ||
| $872.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$121.91M | ||
| $86.26M | ||
| $30.82M | ||
| $447.00K | ||
| -$122.36M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| HC Wainwright & Co. | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Jefferies | → | |
| UBS | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| Jefferies | → |
Analyst sentiment
Institutional ownership
Screeners with ALXO
FAQ
What is the ticker symbol for ALX Oncology Holdings Inc.?
The ticker symbol for ALX Oncology Holdings Inc. is NASDAQ:ALXO
Does ALX Oncology Holdings Inc. pay dividends?
No, ALX Oncology Holdings Inc. does not pay dividends
What sector is ALX Oncology Holdings Inc. in?
ALX Oncology Holdings Inc. is in the Healthcare sector
What industry is ALX Oncology Holdings Inc. in?
ALX Oncology Holdings Inc. is in the Biotechnology industry
What country is ALX Oncology Holdings Inc. based in?
ALX Oncology Holdings Inc. is headquartered in United States
When did ALX Oncology Holdings Inc. go public?
ALX Oncology Holdings Inc. initial public offering (IPO) was on July 17, 2020
Is ALX Oncology Holdings Inc. in the S&P 500?
No, ALX Oncology Holdings Inc. is not included in the S&P 500 index
Is ALX Oncology Holdings Inc. in the NASDAQ 100?
No, ALX Oncology Holdings Inc. is not included in the NASDAQ 100 index
Is ALX Oncology Holdings Inc. in the Dow Jones?
No, ALX Oncology Holdings Inc. is not included in the Dow Jones index
When was ALX Oncology Holdings Inc. last earnings report?
ALX Oncology Holdings Inc.'s most recent earnings report was on November 7, 2025
When does ALX Oncology Holdings Inc. report earnings?
The next expected earnings date for ALX Oncology Holdings Inc. is March 5, 2026
Data Sources & References
- ALXO Official Website www.alxoncology.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1810182/000119312525272281/0001193125-25-272281-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1810182/000095017025034761/0000950170-25-034761-index.htm
- ALXO Profile on Yahoo Finance finance.yahoo.com/quote/ALXO
- ALXO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alxo